Literature DB >> 1640429

Attitudes towards prenatal diagnosis and carrier screening for cystic fibrosis among the parents of patients in a paediatric cystic fibrosis clinic.

E K Watson1, J Marchant, A Bush, B Williamson.   

Abstract

The parents of all children attending the Royal Brompton National Heart and Lung Hospital cystic fibrosis paediatric clinic were asked to complete an anonymous postal questionnaire addressing attitudes towards prenatal diagnosis and population carrier screening for cystic fibrosis (CF); 65% (170/261) of parents responded. Of the respondents, 92% would support the introduction of a population screening test to detect carriers of CF and 19% felt such a test should be mandatory. A total of 64% of CF parents felt they would choose not to have any further children in the knowledge that they were both carriers, 74% would choose to have a prenatal test if they became pregnant, 44% would consider terminating an affected pregnancy, 33% would not, and 23% were unsure. Overall, 72% of respondents indicated they would choose to avoid having a further child with CF either by not having further children or by terminating an affected pregnancy.

Entities:  

Keywords:  Empirical Approach; Genetics and Reproduction; Health Care and Public Health

Mesh:

Year:  1992        PMID: 1640429      PMCID: PMC1016026     

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  6 in total

1.  The incidence of delta F508 CF mutation, and associated haplotypes, in a sample of English CF families.

Authors:  E K Watson; E S Mayall; L Simova; E M Thompson; J O Warner; R Williamson; C Williams
Journal:  Hum Genet       Date:  1990-09       Impact factor: 4.132

2.  Attitudes to carrier screening for cystic fibrosis: a survey of health care professionals, relatives of sufferers and other members of the public.

Authors:  E K Watson; R Williamson; J Chapple
Journal:  Br J Gen Pract       Date:  1991-06       Impact factor: 5.386

3.  Identification of the cystic fibrosis gene: genetic analysis.

Authors:  B Kerem; J M Rommens; J A Buchanan; D Markiewicz; T K Cox; A Chakravarti; M Buchwald; L C Tsui
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

4.  Simple non-invasive method to obtain DNA for gene analysis.

Authors:  N Lench; P Stanier; R Williamson
Journal:  Lancet       Date:  1988-06-18       Impact factor: 79.321

5.  Attitudes of parents of cystic fibrosis children towards neonatal screening and antenatal diagnosis.

Authors:  L N al-Jader; M C Goodchild; H C Ryley; P S Harper
Journal:  Clin Genet       Date:  1990-12       Impact factor: 4.438

6.  Screening for carriers of cystic fibrosis through primary health care services.

Authors:  E K Watson; E Mayall; J Chapple; M Dalziel; K Harrington; C Williams; R Williamson
Journal:  BMJ       Date:  1991-08-31
  6 in total
  12 in total

1.  Attitudes toward cystic fibrosis carrier and prenatal testing and utilization of carrier testing among relatives of individuals with cystic fibrosis.

Authors:  DeeDee Lafayette; Dianne Abuelo; Mary Ann Passero; Umadevi Tantravahi
Journal:  J Genet Couns       Date:  1999-02       Impact factor: 2.537

2.  Cystic fibrosis genotypes and views on screening are both heterogeneous and population related.

Authors:  C R Scriver; T M Fujiwara
Journal:  Am J Hum Genet       Date:  1992-11       Impact factor: 11.025

3.  Consumers' desire towards current and prospective reproductive genetic testing.

Authors:  Feighanne Hathaway; Esther Burns; Harry Ostrer
Journal:  J Genet Couns       Date:  2009-01-22       Impact factor: 2.537

4.  Attitudes of health care professionals toward carrier screening for cystic fibrosis. A review of the literature.

Authors:  S Janssens; A De Paepe; P Borry
Journal:  J Community Genet       Date:  2012-12-29

5.  Reproductive decisions after neonatal screening identifies cystic fibrosis.

Authors:  T Dudding; B Wilcken; B Burgess; J Hambly; G Turner
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-03       Impact factor: 5.747

6.  Update and Review: Cystic Fibrosis.

Authors:  T Brown; E L Schwind
Journal:  J Genet Couns       Date:  1999-06       Impact factor: 2.537

7.  Prenatal diagnosis and a donor splice site mutation in fibrillin in a family with Marfan syndrome.

Authors:  M Godfrey; N Vandemark; M Wang; M Velinov; D Wargowski; P Tsipouras; J Han; J Becker; W Robertson; S Droste
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

8.  Psychosocial functioning of young adults with cystic fibrosis and their families.

Authors:  C Blair; A Cull; C P Freeman
Journal:  Thorax       Date:  1994-08       Impact factor: 9.139

9.  Counseling and screening for cystic fibrosis in patients with congenital bilateral absence of the vas deferens: Patient perceptions.

Authors:  J L Fitzpatrick; E M Hutton; R Babul; C S Cytrynbaum; J E Sutherland; C T Shuman
Journal:  J Genet Couns       Date:  1996-03       Impact factor: 2.537

10.  Attitudes of cystic fibrosis patients and parents toward carrier screening and related reproductive issues.

Authors:  Sandra Janssens; Davit Chokoshvilli; Carmen Binst; Inge Mahieu; Lidewij Henneman; Anne De Paepe; Pascal Borry
Journal:  Eur J Hum Genet       Date:  2015-07-29       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.